Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 9, Number 3, July 2010

Articles

Commentary (Research Highlights)
pp. 257-257(1)
Author: D. Skaper, Stephen

Favourites:
ADD

The Role of Autophagy: What can be Learned from the Genetic Forms of Amyotrophic Lateral Sclerosis
pp. 268-278(11)
Authors: Pasquali, Livia; Ruffoli, Riccardo; Fulceri, Federica; Pietracupa, Sara; Siciliano, Gabriele; Paparelli, Antonio; Fornai, Francesco

Favourites:
ADD

Histone Deacetylation and Motor Neuron Degeneration
pp. 279-284(6)
Authors: Schmalbach, S.; Petri, S.

Favourites:
ADD

Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
pp. 285-296(12)
Authors: Ticozzi, N.; Ratti, A.; Silani, V.

Favourites:
ADD

Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target
pp. 297-304(8)
Authors: Bogaert, E.; d'Ydewalle, C.; Van Den Bosch, L.

Favourites:
ADD

Clinical Trials for Neuroprotection in ALS
pp. 305-313(9)
Authors: Siciliano, G.; Carlesi, C.; Pasquali, L.; Piazza, S.; Pietracupa, S.; Fornai, F.; Ruggieri, S.; Murri, L.

Favourites:
ADD

Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
pp. 314-324(11)
Authors: Silani, V.; Calzarossa, C.; Cova, L.; Ticozzi, N.

Favourites:
ADD
Favourites:
ADD

Repetitive Transcranial Magnetic Stimulation for ALS
pp. 331-334(4)
Authors: Dileone, M.; Profice, P.; Pilato, F.; Ranieri, F.; Capone, F.; Musumeci, G.; Florio, L.; Di Iorio, R.; Di Lazzaro, V.

Favourites:
ADD

Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
pp. 335-348(14)
Authors: Schmidt, A.L.; Brunetto, A.L.; Schwartsmann, G.; Roesler, R.; Abujamra, A.L.

Favourites:
ADD

Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease
pp. 349-372(24)
Authors: L'Episcopo, Francesca; Tirolo, Cataldo; Testa, Nuccio; Caniglia, Salvo; Concetta Morale, Maria; Marchetti, Bianca

Favourites:
ADD

Mechanisms of Oxidative Glutamate Toxicity: The Glutamate/Cystine Antiporter System xc¯ as a Neuroprotective Drug Target
pp. 373-382(10)
Authors: Albrecht, Philipp; Lewerenz, Jan; Dittmer, Sonja; Noack, Rebecca; Maher, Pamela; Methner, Axel

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more